Wellness is the new status symbol. But what if you can’t afford oxygen tanks, NAD+ IV drips, and cryotherapy? What if you’re ...

Managing health from the comfort of your home has never been easier. With the rise of personal wellness tools, devices like a ...

IRadimed Corporation offers steady revenue growth with 14 consecutive quarters of record revenue and a small dividend, ...

Cullinan Therapeutics rebranded from oncology to immunology+oncology, focusing on CD19 TCEs for autoimmune diseases. Check ...

NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of ...

Trends & Forecast 2022-2032The global IV infusion gravity bags market is experiencing remarkable growth, fueled by the increasing need for efficient fluid delivery systems in healthcare settings.

The findings reinforce the potential of BRIUMVI in improving patient outcomes for those seeking an alternative to their previous anti-CD20 therapy. Furthermore, the article in CNS DRUGS offers an ...

Lying on a turquoise hospital gurney, hooked up to a drip of clear, sparkling fluid, I can feel a tingling sensation pulsing through my body.

Roche’s phase III MUSETTE trial of Ocrevus high dose in people with relapsing multiple sclerosis fails to meet primary endpoint: Basel Friday, April 4, 2025, 11:00 Hrs [IST] Roc ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase III MUSETTE trial comparing a high dose of Ocrevus® (ocrelizumab) intravenous (IV) infusion to the ...

Valeriya had received a NAD+ IV drip at a clinic but no prior medical tests were conducted. “They never even gave me a consent form at the start. It was only handed to me after the three-hour ...

were consistent with intravenous (IV) Keytruda chemotherapy. Based on this data, the US Food and Drug Administration (FDA) has accepted a biologics licence application (BLA) for SC Keytruda. A ...